SCHEMBL699531

SCHEMBL699531

CC(C)(C)OC(=O)N1C(=O)C(=Cc2ccccc2)c2ccc(Cl)cc21

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.43
APP P05067 1/20 0.43
SNCA P37840 1/20 0.43
LRRK2 Q5S007 1/20 0.39
BCHE P06276 1/20 0.39
MDM4 O15151 1/20 0.39
TP53 P04637 1/20 0.39
MDM2 Q00987 1/20 0.39
ITGA4 P13612 2/20 0.38
ITGB7 P26010 2/20 0.38
MEN1 O00255 4/20 0.37
KMT2A Q03164 4/20 0.37
L3MBTL1 Q9Y468 2/20 0.37
PIM1 P11309 1/20 0.37
PPARG P37231 1/20 0.37
NFKB1 P19838 2/20 0.36
NFKB2 Q00653 2/20 0.36
RELA Q04206 2/20 0.36
HPGD P15428 1/20 0.36
CDC25A P30304 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL274463 0.93 MDM4 (0.43) MAPTAPPSNCABCHEMDM4
SCHEMBL277025 0.93 MDM4 (0.43) MAPTAPPSNCABCHEMDM4
SCHEMBL274462 0.93 MDM4 (0.43) MAPTAPPSNCABCHEMDM4
SCHEMBL275607 0.89 PPARG (0.45) MAPTAPPSNCAMDM4TP53
SCHEMBL279165 0.89 PPARG (0.45) MAPTAPPSNCAMDM4TP53
SCHEMBL275608 0.89 PPARG (0.45) MAPTAPPSNCAMDM4TP53
SCHEMBL7786836 0.88 MAPT (0.42) MAPTMDM2
SCHEMBL27740824 0.87 MDM4 (0.51) MAPTAPPSNCABCHEMDM4
SCHEMBL275659 0.86 APP (0.35) MAPTAPPSNCALRRK2BCHE
SCHEMBL275658 0.86 APP (0.35) MAPTAPPSNCALRRK2BCHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2421866-A1 3,3'-SPIROINDOLINONE DERIVATIVES AND THEIR USE FOR CANCER F. Hoffmann-La Roche AG (CH) 2012-02-29 EP disclosed
WO-2010121995-A1 3,3'-SPIROINDOLINONE DERIVATIVES AND THEIR USE FOR CANCER F. HOFFMANN-LA ROCHE AG (CH) 2010-10-28 WO disclosed